%0 Case Reports
%T A Rare Case of Complete-Immunotherapy-Responsive Metastatic Non-Small Cell Lung Cancer with Long Lasting Progression-Free Survival: A Case Report.
%A De Intinis C
%A Izzo P
%A Codacci-Pisanelli M
%A Izzo L
%A Messineo D
%A Sibio S
%A Campagnol M
%A Lai S
%A Molle M
%A Izzo S
%J Curr Oncol
%V 31
%N 2
%D 2024 01 26
%M 38392047
%F 3.109
%R 10.3390/curroncol31020053
%X Lung cancer is a prevalent and deadly disease globally. Non-small cell lung cancer (NSCLC) is the most common subtype, comprising 85% of cases.<BR>A 65-year-old male ex-smoker presented to our facility with a nocturnal cough. Various investigations revealed that he had metastatic NSCLC, for which he underwent chemotherapy with cisplatin and gemcitabine, followed by immunotherapy with Nivolumab. He achieved a complete response to the therapy and has remained free from recurrence for over 7 years since the initial diagnosis.<BR>The treatment of metastatic NSCLC remains a significant therapeutic challenge, but the implementation of new therapeutic techniques has expanded the possibilities of achieving complete and durable eradication of the disease.